News & Articles
Selected Filters:
Using DNA repair and machine learning to improve cancer risk prediction
Scientists are harnessing machine learning to make accurate measurements of breast cancer risk from a patient’s blood cells
SelectScience announces new Virtual Clinical Chemistry Summit 2020
Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier
Thermo Fisher, Daiichi Sankyo partner on global companion diagnostic device
The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients
Promega announces CE marking for OncoMate MSI Dx Analysis System
New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers
How to Buy Clinical Automation Technology eBook: 2020 edition
Your guide to choosing and implementing the best automated solutions for the clinical laboratory
Vote for Best New Clinical Laboratory Product of 2019 in the Scientists’ Choice Awards
To be in with a chance of winning a $500 Amazon Gift Card, simply cast your vote for the product that has made the most difference to your work
HORIBA Medical and CellaVision collaborate on new automated Digital Cell Morphology solution to enhance lab workflows
CellaVision integration with HORIBA’s HELO automated hematology platform enables unique two-way data flow and rapid results validation
Harnessing the immune system to revolutionize cancer therapy – your questions answered
Watch this on-demand webinar to learn about the applications for cell-based therapies and biologics using advanced high-throughput flow cytometry
New trial to repurpose cancer drug for COVID-19 patients
The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients
First results from human COVID-19 immunology study reveal universally effective antibodies
People who recovered from COVID-19 shows that most individuals had generated antibodies that were intrinsically capable of neutralizing the SARS-CoV-2 virus
Pancreatic cancer-derived organoids and multimodal plate imaging to predict drug responses
Register for this webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine
Abbott’s ID NOW COVID-19 rapid test shows strong agreement to PCR instruments
Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity
Agilent PD-L1 assay receives FDA approval for use as a companion diagnostic
Assay will help guide treatment decisions in cases of non-small cell lung cancer
Join the SelectScience Virtual Summit on Cancer and Immunology Research 2020 - May 11-13
Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11
AstraZeneca and Oxford University join forces for coronavirus vaccine
Collaboration will enable global development, manufacturing and distribution of the vaccine
Abbott obtains CE mark for COVID-19 laboratory-based antibody test
The test will be available for qualified laboratories across the European Union by the end of May
11 top technologies advancing coronavirus research
Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease
Lab-based coronavirus test aims to deliver up to 46,000 results a day
The testing capability of Mologic's kits is expected to relieve immediate testing pressures in the UK and Africa
Bio-Rad to launch blood-based immunoassay kit to detect COVID-19 antibodies
The serology immunoassay kit aims to help clinicians diagnose the coronavirus by analyzing the immune response against SARS-CoV-2
Partnership to scale-up GMP manufacturing of a COVID-19 vaccine announced
Alliance for the scale-up of a GMP manufacturing process and production of a coronavirus (SARS-CoV-2) vaccine (ChAdOx1 nCoV-19) formed
AstraZeneca collaborates with Silence Therapeutics to develop siRNA therapeutics
The collaboration aims to develop novel, targeted treatments to address significant unmet needs
New SARS-CoV-2 gene variants may provide clues to coronavirus' epidemiology
Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development
Proteona to develop SARS-CoV-2 neutralizing antibody against COVID-19
AI-driven proteogenomic analysis company applies single-cell analysis expertise to develop treatments for COVID-19
Abbott obtains FDA emergency use authorization and launches COVID-19 test
The test will be used on the m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.